-
公开(公告)号:US20140094604A1
公开(公告)日:2014-04-03
申请号:US14009788
申请日:2012-04-06
申请人: Vinod Kumar Kansal , Dhirenkumar Mistry , Sanjay Vasoya , Ghanshyam Pandey , Amlt Taneja , Pramond Kadappa , Jiri Stohandl , Jaroslay Frantisek
发明人: Vinod Kumar Kansal , Dhirenkumar Mistry , Sanjay Vasoya , Ghanshyam Pandey , Amlt Taneja , Pramond Kadappa , Jiri Stohandl , Jaroslay Frantisek
IPC分类号: C07D487/04 , C07D239/47 , C07D405/12
CPC分类号: C07D239/47 , B05B1/1636 , C07D239/48 , C07D405/12 , C07D487/04
摘要: The present invention is related to new intermediates and processes for preparing Ticagrelor disclosed in this patent application.
摘要翻译: 本发明涉及本专利申请中公开的新中间体和制备替卡格雷的方法。
-
公开(公告)号:US09056838B2
公开(公告)日:2015-06-16
申请号:US14009788
申请日:2012-04-06
申请人: Vinod Kumar Kansal , Dhirenkumar Mistry , Sanjay Vasoya , Ghanshyam Pandey , Amit Taneja , Pramod Kadappa Shindey , Jiri Stohandl , Jaroslav Frantisek
发明人: Vinod Kumar Kansal , Dhirenkumar Mistry , Sanjay Vasoya , Ghanshyam Pandey , Amit Taneja , Pramod Kadappa Shindey , Jiri Stohandl , Jaroslav Frantisek
IPC分类号: C07D239/47 , C07D487/04 , C07D239/48 , B05B1/16 , C07D405/12
CPC分类号: C07D239/47 , B05B1/1636 , C07D239/48 , C07D405/12 , C07D487/04
摘要: The present invention is related to new intermediates and processes for preparing Ticagrelor disclosed in this patent application. One of the embodiments of the invention provides a process for preparing Ticagrelor of Formula I, comprising coupling a compound of Formula VI, with a compound of Formula IX,
摘要翻译: 本发明涉及本专利申请中公开的新中间体和制备替卡格雷的方法。 本发明的一个实施方案提供了制备式I的泰格列洛的方法,包括将式VI化合物与式IX的化合物,
-
3.
公开(公告)号:US20080103312A1
公开(公告)日:2008-05-01
申请号:US11897173
申请日:2007-08-28
IPC分类号: C07D257/04
CPC分类号: C07D257/04 , C07D403/10
摘要: Provided are processes for the synthesis of 5-phenyl-1-trityl-1H-tetrazole, an intermediate useful in the synthesis of irbesartan.
摘要翻译: 提供了用于合成厄贝沙坦的中间体5-苯基-1-三苯甲基-1H-四唑的合成方法。
-
公开(公告)号:US20070123573A1
公开(公告)日:2007-05-31
申请号:US10588564
申请日:2005-04-25
申请人: Dhiren Mistry , Kamlesh Soni , Sanjay Vasoya , Vinod Kansal
发明人: Dhiren Mistry , Kamlesh Soni , Sanjay Vasoya , Vinod Kansal
IPC分类号: A61K31/428 , C07D277/82
CPC分类号: C07D277/82
摘要: Improved process for the preparation of the intermediate compound of formula II for formation of biological active tetrahydrobenzothiazole compound of formula (I) as well as the biological active tetrahydrobenzothiazole compound of formula (I) and/or its pharmaceutically acceptable salts or solvates. The process comprises reacting 4-amino cyclohexanol of formula (III) or its acid addition salts with phthalic anhydride in presence of acid catalyst and their salts, in polar aprotic solvent or its mixture with organic solvent, capable of removing water azeotropically to give 4-(phthalimido)-cyclohexanol of formula (IV); oxidizing 4-(phthalimido)-cyclohexanol of formula (IV) to give 4-(phthalimido)-cyclohexanone of formula (V); brominating 4-(phthalimido)-cyclohexanone of formula (V) with brominating agent in organic solvent in presence of Lewis acid catalyst to prepare 2-bromo-4-(phthalimido)-cyclohexanone of formula (VI); treating 2-bromo-4-(phthalimido)-cyclohexanone of formula (VI) with thiourea in organic solvent in presence of base to give 2-amino-6-phthalimido-4,5,6,7-tetrahydro benzothiazol of formula (VII); reacting compound of formula (VII) with hydrazine hydrate and base in polar solvent to give racemic 2,6-diamino-4,5,6,7-tetrahydro-1,3-benzothiazole of formula (VIII); resolving racemic 2,6-diamino-4,5,6,7-tetrahydro-1,3-benzothiazole of formula (VIII) to prepare (6S)-2,6-diamino-4,5,6,7-tetrahydro-1,3-benzothiazole of formula (II). To form the compound of Formula I and if desired its salts/solvates the above process is carried out with further steps of coupling (6S)-2,6-dimino-4,5,6,7-tetrahydro-1,3-benzothiazole of formula (II) with propionaldehyde in presence of mineral acid in polar organic solvent and reducing agent to prepare (S)-(−)-2-Amino-6-(n-propylamino)-4,5,6,7-tetrahydrobenzothiazole of formula (I);and if desired converting (S)-(−)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazole to its pharmaceutically acceptable salts or solvates.
-
公开(公告)号:US20060258878A1
公开(公告)日:2006-11-16
申请号:US11491638
申请日:2006-07-24
申请人: Rohit Soni , Sanjay Vasoya , Ravindra Ghotikar , Anand Pandey , Hetal Shah
发明人: Rohit Soni , Sanjay Vasoya , Ravindra Ghotikar , Anand Pandey , Hetal Shah
IPC分类号: C07C255/49
CPC分类号: C07D257/04 , C07C255/58
摘要: The invention relates to novel compound of formula (IV), which is an organic acid salt of N-[(2′-cyanobiphenyl-4-yl)methyl]-(L)-valine ester. This compound is an useful intermediate for process of preparation of Valsartan of formula (I), chemically known as (S)—N-(1-Carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2′-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]amine. This invention also relates to a process for preparing Valsartan using novel intermediate of formula (IV).
摘要翻译: 本发明涉及新的式(Ⅳ)化合物,它是N - [(2'-氰基联苯-4-基)甲基] - (L) - 缬氨酸酯的有机酸盐。 该化合物是制备式(I)的缬沙坦的方法的有用的中间体,化学上称为(S)-N-(1-羧基-2-甲基丙-1-基)-N-戊酰基-N- [2' - (1H-四唑-5-基)联苯-4-基甲基]胺。 本发明还涉及使用式(IV)的新型中间体制备缬沙坦的方法。
-
-
-
-